ALS

Study of Safety, Tolerability, and Biological Activity of LAM-002A in C9ORF72-Associated Amyotrophic Lateral Sclerosis

PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

Study of [11C]CPPC as a Clinical PET Radioligand Biomarker of Microglial Activation in ALS

Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS

Scalable Expanded Access With Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALS

Using the EHR to Advance Genomic Medicine Across a Diverse Health System

Initiation of Noninvasive Ventilation in ALS Patients With Chronic Respiratory Insufficiency

Digital Speech Markers for Monitoring ALS in Spanish Speakers

Multicenter ALS Imaging Study

Multimodal Tracking of Therapy Activity and Effort During Rehabilitation

Healey ALS MyMatch Common Screening Protocol

Extension Study Following the Studies MT-1186-A03 or A04 to Evaluate the Safety of Oral Edaravone in Subjects With ALS

Safety Study of Oral Edaravone Administered in Subjects With ALS

Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS

A Study of TCD601 (Siplizumab) in Newly Diagnosed Adult Amyotrophic Lateral Sclerosis (ALS) Patients

Intravenous Immunoglobulin (IVIG) and Blood-Brain Barrier Disruption in Amyotrophic Lateral Sclerosis (ALS)

The BANYAN Trial, an ALS MyMatch Trial Evaluating Safety, Biomarker Activity, and Microglial Activation of Nasal Foralumab

Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)

Digital Tools for Assessment of Motor Functions and Falls in ALS

Neurologic Stem Cell Treatment Study